Fr. 70.00

Interleukin-27: Biological Properties and Clinical Application

Inglese · Tascabile

Spedizione di solito entro 6 a 7 settimane

Descrizione

Ulteriori informazioni

This volume focuses on various aspects of interleukin-27 (IL-27), especially its potential for clinical applications. The authors discuss the downstream signaling from the IL-27 receptor and its molecular targets in immune cells including Th1, Th2, Th17, Treg, Tr1, Tfh, B cells, DCs and macrophages. The inhibition of Th17 cells by IL-27 is vital for the maintenance of the feto-maternal tolerance and the prevention of lupus, multiple sclerosis, autoimmune uveitis, immune thrombocytopenia and atherosclerosis. However, the same inhibitory capabilities compromise the immune response to bacterial pathogens, and IL-27 is a pathogenic factor in sepsis and tuberculosis. Also covered are the conflicting reports on the role of IL-27 in rheumatoid arthritis, the effect of IL-27 on epithelia, which seems to play a role in asthma, psoriasis and inflammatory bowel diseases, and the direct cytotoxic and anti-vascular effects of IL-27, which make it a promising agent for the treatment of cancer. Accordingly, this volume will be of interest to researchers and clinicians alike.

Sommario

IL-27: Structure, Regulation and Variability.- IL-27: A Key Player in Immune Regulation.- IL-27 in Health and Disease.

Riassunto

This volume focuses on various aspects of interleukin-27 (IL-27), especially its potential for clinical applications. The authors discuss the downstream signaling from the IL-27 receptor and its molecular targets in immune cells including Th1, Th2, Th17, Treg, Tr1, Tfh, B cells, DCs and macrophages. The inhibition of Th17 cells by IL-27 is vital for the maintenance of the feto-maternal tolerance and the prevention of lupus, multiple sclerosis, autoimmune uveitis, immune thrombocytopenia and atherosclerosis. However, the same inhibitory capabilities compromise the immune response to bacterial pathogens, and IL-27 is a pathogenic factor in sepsis and tuberculosis. Also covered are the conflicting reports on the role of IL-27 in rheumatoid arthritis, the effect of IL-27 on epithelia, which seems to play a role in asthma, psoriasis and inflammatory bowel diseases, and the direct cytotoxic and anti-vascular effects of IL-27, which make it a promising agent for the treatment of cancer. Accordingly, this volume will be of interest to researchers and clinicians alike.

Dettagli sul prodotto

Autori Andrzej Eljaszewicz, Mare Jankowski, Marek Jankowski, Tomasz Wandtke
Con la collaborazione di Marta Jakubowska (Illustrazione)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 01.01.2016
 
EAN 9783319396620
ISBN 978-3-31-939662-0
Pagine 86
Dimensioni 156 mm x 235 mm x 6 mm
Peso 154 g
Illustrazioni VI, 86 p. 5 illus. in color.
Serie SpringerBriefs in Immunology
SpringerBriefs in Immunology
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Branche non cliniche

C, Zellbiologie (Zytologie), Immunology, Psoriasis, COPD, infectious diseases, Biomedical and Life Sciences, atherosclerosis, Cellular biology (cytology), Growth factors, Cytokines, Cytokines and Growth Factors, inflammatory bowel disease, Feto-maternal tolerance, IL-27, Autoimmune disorders, Autoimmune uveitis

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.